Table 1.
Group K | Group P | |
---|---|---|
N | 15 | 15 |
Age (y) | 60.3 ± 2.7 | 58.8 ± 2.2 |
Weight (kg) | 77.9 ± 2.5 | 78.5 ± 2.9 |
Body surface area (m2) | 1.87 ± 0.12 | 1.88 ± 0.14 |
Sex (F/M) | 4/11 | 3/12 |
LVEDP (mmHg) | 9.5 ± 2.9 | 9.3 ± 3.1 |
Canadian Class II/III/IV | 1/10/4 | 5/6/4 |
Medications n (%) | ||
Nitrates | 10 (66.6 %) | 11 (73.3 %) |
Beta-blockers | 7 (46.6 %) | 9 (60 %) |
Calcium channel blockers | 4 (26.6 %) | 3 (20%) |
Anti-hypertensive | 1 (6.6 %) | 1 (6.6 %) |
LVEDP: left ventricular end-diastolic pressure. Data are presented as mean ± SD or number of patients.